Oseltamivir distributes to influenza virus replication sites in the middle ear and sinuses.

This publication has 16 references indexed in Scilit:

• Oral oseltamivir treatment of influenza in children
  The Pediatric Infectious Disease Journal, 2001
• Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom
  European Journal of Clinical Microbiology & Infectious Diseases, 2000
• Influenza A Virus Infection of Human Middle Ear Cells In Vitro
  The Laryngoscope, 2000
• Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 2000
• Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
  The Lancet, 2000
• Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
  JAMA, 2000
• Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media
  New England Journal of Medicine, 1999
• Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802
  Clinical Pharmacokinetics, 1999
• In-vitro and in-vivo efficacy of influenza neuraminidase inhibitors
  Current Opinion in Infectious Diseases, 1998
• Respiratory mucus pH in tracheostomized intensive care unit patients
  Critical Care Medicine, 1990